Published in Vaccine Weekly, May 24th, 1999
In this study, researcher S.M. Akbar and colleagues from Japan's Ehime University sought to identify a prognostic marker of vaccine therapy using an animal model of HBV-carrier state, HBV-transgenic mice (Tg) ("Prognostic Importance of Antigen-Presenting Dendritic Cells During Vaccine Therapy in a Murine Hepatitis B Virus Carrier," Immunology, 1999;96(1):98-108).
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.